Status:
RECRUITING
Preoperative Endoscopic Pancreatic Stent for Distal Pancreatectomy
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Pancreatectomy
Pancreatic Fistula
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Distal pancreatectomy (DP) with or without splenectomy is commonly indicated for pancreatic body or tail lesions. Postoperative pancreatic fistula (POPF) remains the commonest complication after DP. A...
Detailed Description
A randomised-controlled trial is performed to evaluate the efficacy of preoperative pancreatic duct stenting in preventing post-operative pancreatic fistula after distal pancreatectomy with or without...
Eligibility Criteria
Inclusion
- Age \>18 years
- Elective distal pancreatectomy for primary pancreatic pathology
Exclusion
- Informed consent not available
- Emergency distal pancreatectomy
- Presence of pancreatic duct stricture
- Presence of altered anatomy that precludes safe Endoscopic Retrograde Cholangiography (e.g. previous Billroth II gastrectomy)
- History of severe pancreatitis
Key Trial Info
Start Date :
March 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 20 2026
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT05297136
Start Date
March 21 2022
End Date
May 20 2026
Last Update
March 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong